ADVM
Adverum Biotechnologies
ADVM
ADVM
Delisted
ADVM was delisted on the 8th of December, 2025.
58 hedge funds and large institutions have $30.1M invested in Adverum Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
57% less capital invested
Capital invested by funds: $69.8M → $30.1M (-$39.7M)
Holders
58
Holding in Top 10
4
Calls
$3K
Puts
$4K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$958K | |
| 3 | +$930K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$882K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$219K |
Top Sellers
| 1 | -$7.69M | |
| 2 | -$2.83M | |
| 3 | -$826K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$745K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$407K |